vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与UiPath, Inc.（PATH）财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.3倍（$411.1M vs $321.1M），UiPath, Inc.净利率更高（48.4% vs -18.2%，领先66.6%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 15.9%），UiPath, Inc.自由现金流更多（$25.1M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
MDGL vs PATH — 直观对比
营收规模更大
PATH
是对方的1.3倍
$321.1M
营收增速更快
MDGL
高出194.8%
15.9%
净利率更高
PATH
高出66.6%
-18.2%
自由现金流更多
PATH
多$159.0M
$-133.8M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $411.1M |
| 净利润 | $-58.6M | $198.8M |
| 毛利率 | — | 83.3% |
| 营业利润率 | -18.6% | 3.2% |
| 净利率 | -18.2% | 48.4% |
| 营收同比 | 210.8% | 15.9% |
| 净利润同比 | 1.4% | 1966.2% |
| 每股收益（稀释后） | $-2.55 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLPATH
| Q4 25 | $321.1M | $411.1M | ||
| Q3 25 | $287.3M | $361.7M | ||
| Q2 25 | $212.8M | $356.6M | ||
| Q1 25 | $137.3M | $423.6M | ||
| Q4 24 | $103.3M | $354.7M | ||
| Q3 24 | $62.2M | $316.3M | ||
| Q2 24 | — | $335.1M | ||
| Q1 24 | $0 | $405.3M |
净利润MDGLPATH
| Q4 25 | $-58.6M | $198.8M | ||
| Q3 25 | $-114.2M | $1.6M | ||
| Q2 25 | $-42.3M | $-22.6M | ||
| Q1 25 | $-73.2M | $51.8M | ||
| Q4 24 | $-59.4M | $-10.7M | ||
| Q3 24 | $-107.0M | $-86.1M | ||
| Q2 24 | — | $-28.7M | ||
| Q1 24 | $-147.5M | $33.9M |
毛利率MDGLPATH
| Q4 25 | — | 83.3% | ||
| Q3 25 | — | 82.2% | ||
| Q2 25 | — | 82.1% | ||
| Q1 25 | 96.7% | 84.8% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 83.5% | ||
| Q1 24 | — | 86.8% |
营业利润率MDGLPATH
| Q4 25 | -18.6% | 3.2% | ||
| Q3 25 | -39.7% | -5.6% | ||
| Q2 25 | -22.2% | -4.6% | ||
| Q1 25 | -57.8% | 7.9% | ||
| Q4 24 | -64.8% | -12.2% | ||
| Q3 24 | -187.1% | -32.7% | ||
| Q2 24 | — | -14.8% | ||
| Q1 24 | — | 3.7% |
净利率MDGLPATH
| Q4 25 | -18.2% | 48.4% | ||
| Q3 25 | -39.8% | 0.4% | ||
| Q2 25 | -19.9% | -6.3% | ||
| Q1 25 | -53.4% | 12.2% | ||
| Q4 24 | -57.5% | -3.0% | ||
| Q3 24 | -172.0% | -27.2% | ||
| Q2 24 | — | -8.6% | ||
| Q1 24 | — | 8.4% |
每股收益（稀释后）MDGLPATH
| Q4 25 | $-2.55 | $0.37 | ||
| Q3 25 | $-5.08 | $0.00 | ||
| Q2 25 | $-1.90 | $-0.04 | ||
| Q1 25 | $-3.32 | $0.09 | ||
| Q4 24 | $-2.50 | $-0.02 | ||
| Q3 24 | $-4.92 | $-0.15 | ||
| Q2 24 | — | $-0.05 | ||
| Q1 24 | $-7.38 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $1.4B |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $1.9B |
| 总资产 | $1.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLPATH
| Q4 25 | $198.7M | $1.4B | ||
| Q3 25 | $295.7M | $1.4B | ||
| Q2 25 | $186.2M | $1.6B | ||
| Q1 25 | $183.6M | $1.6B | ||
| Q4 24 | $100.0M | $1.6B | ||
| Q3 24 | $232.7M | $1.7B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | $622.5M | $1.9B |
总债务MDGLPATH
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | — |
股东权益MDGLPATH
| Q4 25 | $602.7M | $1.9B | ||
| Q3 25 | $625.7M | $1.7B | ||
| Q2 25 | $696.0M | $1.7B | ||
| Q1 25 | $710.6M | $1.8B | ||
| Q4 24 | $754.4M | $1.7B | ||
| Q3 24 | $777.2M | $1.8B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $850.8M | $2.0B |
总资产MDGLPATH
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.4B | $2.6B | ||
| Q2 25 | $1.0B | $2.6B | ||
| Q1 25 | $996.6M | $2.9B | ||
| Q4 24 | $1.0B | $2.7B | ||
| Q3 24 | $1.1B | $2.7B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | $1.1B | $3.0B |
负债/权益比MDGLPATH
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $25.1M |
| 自由现金流率自由现金流/营收 | -41.7% | 6.1% |
| 资本支出强度资本支出/营收 | 0.1% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.14× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDGLPATH
| Q4 25 | $-133.5M | $28.3M | ||
| Q3 25 | $79.8M | $41.6M | ||
| Q2 25 | $-47.1M | $119.0M | ||
| Q1 25 | $-88.9M | $146.1M | ||
| Q4 24 | $-104.5M | $28.1M | ||
| Q3 24 | $-67.0M | $46.4M | ||
| Q2 24 | — | $100.0M | ||
| Q1 24 | $-149.2M | $145.6M |
自由现金流MDGLPATH
| Q4 25 | $-133.8M | $25.1M | ||
| Q3 25 | $79.0M | — | ||
| Q2 25 | — | $106.2M | ||
| Q1 25 | — | $138.7M | ||
| Q4 24 | $-104.7M | $23.2M | ||
| Q3 24 | $-67.8M | $45.0M | ||
| Q2 24 | — | $98.8M | ||
| Q1 24 | $-149.5M | $141.8M |
自由现金流率MDGLPATH
| Q4 25 | -41.7% | 6.1% | ||
| Q3 25 | 27.5% | — | ||
| Q2 25 | — | 29.8% | ||
| Q1 25 | — | 32.7% | ||
| Q4 24 | -101.3% | 6.5% | ||
| Q3 24 | -109.0% | 14.2% | ||
| Q2 24 | — | 29.5% | ||
| Q1 24 | — | 35.0% |
资本支出强度MDGLPATH
| Q4 25 | 0.1% | 0.8% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.0% | 3.6% | ||
| Q1 25 | 0.0% | 1.7% | ||
| Q4 24 | 0.2% | 1.4% | ||
| Q3 24 | 1.3% | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.9% |
现金转化率MDGLPATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 26.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
